Market revenue in 2020 | USD 338.8 million |
Market revenue in 2028 | USD 508.1 million |
Growth rate | 5.2% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables, Services |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 63.05% in 2024. Horizon Databook has segmented the Australia infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
There is a noticeable increase in microbiology research activities pertaining to development of novel biomarker based diagnostic due to growing prevalence of infectious diseases, such as tuberculosis. According to the Australian Institute of Health and Welfare, in 2017, about 1 in 7 people in the country is aged 65 & above and they are more prone to acquiring or developing diseases, leading to increased disease burden.
The rising target population, consumer awareness, and technological advancements is expected to drive the market in the near future. In addition, various strategic initiatives by local market players, such as launch of new products, are expected to boost the market growth.
For instance, COVID-19 diagnostics research is driven by funding from sources like Medical Research Future Fund. Moreover, the government has also invested over USD 2.6 million to support R&D on diagnostics.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Australia infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account